Latest filing published 30 Mar 2026 for Insight Molecular Diagnostics Inc.. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Josh Riggs in Insight Molecular Diagnostics Inc. Over a trading history stretching from 11 April 2024 to 26 March 2026, the count stands at 2 filings.
The open-market record is one-sided, with 1 purchase worth €9,323 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 option exercise.
The record was last updated on 30 March 2026 with an option exercise in Insight Molecular Diagnostics Inc. The last insider purchase was made public on 15 April 2024, 916 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations